Skip to main content

Peer Review reports

From: Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study

Original Submission
6 Aug 2022 Submitted Original manuscript
30 Aug 2022 Author responded Author comments - Mikhail N. Kalinin
8 Oct 2022 Reviewed Reviewer Report
19 Oct 2022 Reviewed Reviewer Report
19 Oct 2022 Reviewed Reviewer Report
24 Jan 2023 Author responded Author comments - Mikhail N. Kalinin
Resubmission - Version 2
30 Aug 2022 Submitted Manuscript version 2
27 Jan 2023 Reviewed Reviewer Report
27 Jan 2023 Reviewed Reviewer Report
30 Jan 2023 Reviewed Reviewer Report
15 Feb 2023 Author responded Author comments - Mikhail N. Kalinin
Resubmission - Version 3
15 Feb 2023 Submitted Manuscript version 3
Publishing
13 Mar 2023 Editorially accepted
27 Mar 2023 Article published 10.1186/s12883-023-03159-w

You can find further information about peer review here.

Back to article page